FDA Flags Shortage Of Critical Asthma Drug

FDA warns of albuterol shortage

  • The U.S. Food and Drug Administration (FDA) recently warned about a shortage of albuterol, a medication used to aid patients with breathing conditions, including asthma, after its manufacturer halted production.
  • “FDA is working to address a shortage of a particular form of albuterol … a medication that is used to treat breathing conditions. It is important to note that this shortage does not impact albuterol inhalers for personal use,” a post from the FDA read.
  • The FDA flagged the aerosolized form of albuterol that is used in hospitals and nursing homes.
Click to read full article Go back home

Sign Up for Our Newsletter

Join our list!

Sign up here to get our daily newsletter with the top trending headlines.